Rajagopal Bakthavatchalam

USPTO Granted Patents = 40 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 13

Forward Citations = 551(Granted Patents)

Location History:

Wilimington, DE (US) (2001)
Branford, CT (US) (2003 - 2004)
Wilmington, DE (US) (1999 - 2006)
Bengaluru, IN (2018)
Madison, CT (US) (2004 - 2020)

Company Filing History:

Bristol-myers Squibb Pharma Company

patents

6 out of 106

Dupont Pharmaceuticals Company

patents

4. 3 out of 2,078

Janssen Pharmaceutica Nv

patents

5. 3 out of 3,684

Bristol-myers Squibb Compnay

patents

6. 2 out of 15

Dupont Pharmaceuticals, Inc.

Jubilant Biosys Limited

10. 1 out of 832,843

Other

patents

Years Active: 1999-2020

Loading Chart...

Areas of Expertise:

N-Type Calcium Channel Blockers

Substituted Imidazoles

Pyrimidine Compounds

CCR9 Modulators

Melanin Concentrating Hormone Receptor Ligands

Corticotropin Releasing Factor Antagonists

Heterocyclic Amides

Quinazolin-4-Ylamine Analogues

Neurological Disorders

HIV Reverse Transcriptase Inhibitors

Arylthio-Fused Pyridines

Biaryl Piperazinyl-Pyridine Analogues

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10653673 - Substituted imidazoles as N-type calcium channel blockers (2020-05-19),

2. 10273224 - Substituted pyrimidine compounds, compositions and medicinal applications thereof (2019-04-30),

3. 9974775 - Substituted imidazoles as N-type calcium channel blockers (2018-05-22),

4. 9969687 - Compounds useful as CCR9 modulators (2018-05-15),

5. 9453002 - Substituted imidazoles as N-type calcium channel blockers (2016-09-27),

6. 9133204 - 5-membered heterocyclic amides and related compounds (2015-09-15),

7. 8759361 - 2-phenoxy pyrimidinone analogues (2014-06-24),

8. 8003656 - 2-phenoxy pyrimidinone analogues (2011-08-23),

9. 7935702 - Substituted biaryl quinolin-4-ylamine analogues (2011-05-03),

10. 7566712 - Biaryl piperazinyl-pyridine analogues (2009-07-28),

11. 7488740 - Substituted quinolin-4-ylamine analogues (2009-02-10),

12. 7432275 - Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators (2008-10-07),

13. 7329664 - Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues (2008-02-12),

14. 7323478 - Melanin concentrating hormone receptor ligands (2008-01-29),

15. 7304059 - Substituted quinazolin-4-ylamine analogues (2007-12-04),

Title: The Innovative Journey of Rajagopal Bakthavatchalam

Introduction:

Rajagopal Bakthavatchalam is a pioneering inventor based in Madison, CT (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Rajagopal Bakthavatchalam holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his diverse expertise and innovative mindset.

Career Highlights:

With a career spanning over two decades, Rajagopal Bakthavatchalam has worked with leading tech companies and research institutions, consistently pushing the boundaries of innovation. His work has significantly impacted industries such as healthcare, telecommunications, and sustainable energy.

Collaborations:

Throughout his career, Rajagopal Bakthavatchalam has collaborated with top researchers, engineers, and scientists to bring cutting-edge technologies to life. His collaborative spirit and passion for innovation have led to the development of revolutionary products and solutions.

Conclusion:

Rajagopal Bakthavatchalam's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true visionary in the world of inventors. His contributions continue to inspire future generations of innovators to think outside the box and create a better tomorrow.

This text is generated by artificial intelligence and may not be accurate.